# Factors Affecting Methamphetamine and Opiates Drug Testing

> **NCT01736332** · PHASE1 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 29 (actual)

## Conditions studied

- Opiates
- Healthy

## Interventions

- **DRUG:** Vicks VapoInhaler
- **OTHER:** Poppy seeds

## Key facts

- **NCT ID:** NCT01736332
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-19
- **Primary completion:** 2014-01-31
- **Final completion:** 2014-01-31
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01736332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01736332, "Factors Affecting Methamphetamine and Opiates Drug Testing". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01736332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*